Addressing challenges in the clinical applications associated with CRISPR/Cas9 technology and ethical questions to prevent its misuse

Protein Cell. 2017 Nov;8(11):791-795. doi: 10.1007/s13238-017-0477-4.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • CRISPR-Cas Systems*
  • Cystic Fibrosis / genetics
  • Cystic Fibrosis / therapy*
  • Gene Editing / ethics*
  • Genetic Therapy / ethics*
  • Genetic Therapy / methods*
  • Humans
  • Mice
  • Neoplasms / genetics
  • Neoplasms / therapy*